REVIVA PHARMACEUTCLS HLDGS I RVPHW
*W EXP 12/25/202 · Equity WRT · CUSIP 76152G118
5
institutional holders
-1 vs Q1 2024
149.1k
shares reported held*
$38.6kreported value*
0 new
1 added
0 reduced
1 sold out
net sold ≈ $2.4k (-8.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.26.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 7 |
| Q4 2022 | 5 |
| Q1 2023 | 5 |
| Q2 2023 | 4 |
| Q3 2023 | 5 |
| Q4 2023 | 4 |
| Q1 2024 | 6 |
| Q2 2024 | 5 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 5 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 0 | 3 |
| Q3 2023 | 1 | 0 |
| Q4 2023 | 0 | 1 |
| Q1 2024 | 2 | 0 |
| Q2 2024 | 1 | 1 |
Biggest buyers
| UBS Group AG | Added | +2.3k |
Biggest sellers
| B. Riley Wealth Advisors, Inc. | Sold out | -11.1k |
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Arena Investors LP 0.36% of their portfolio | 85.0k $21.2k | Unchanged |
| Walleye Capital LLC 0.00% of their portfolio | 33.7k $9.1k | Unchanged |
| Walleye Trading LLC 0.00% of their portfolio | 25.7k $6.9k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 4.7k $1.3k | Added +2.3k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |